You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

COVID-19: Obtenez les dernières mises à jour ou faites une autoévaluation.

Certaines de ces informations ou toutes, dans certains cas, n’apparaissent qu’en Anglais. Vous pouvez demander la version française

Lignes directrices et conseils
À propos des lignes directrices

Best Practice Recommendations for Regimen Development and Maintenance

ID: GL-C50-25 fév 2016
Type of Content: Guidelines & Advice, Clinical
Document Status: Current
Authors:
CCO Drug Formulary

Guideline Objective

A group of experts from across Ontario developed consensus-based recommendations on the development and maintenance of oncology regimens. These recommendations apply to both intravenous and oral cancer medications, as well as clinical trial regimens for cancer.

Intended Guideline Users

Providers (Physicians, Pharmacists, Nurses)

pdf download Full Report (PDF) (1019.33 Ko)